Results 131 to 140 of about 4,968,629 (297)

Program evaluation of Sea Mar’s Chronic Care Program for Latino and Caucasian patients with type 2 diabetes: providers and staff perspectives

Journal of Multidisciplinary Healthcare, 2012
Gail E Bond,1 Laurie Rechholtz,1 Christina Bosa,1 Celine Impert,1,2 Sara Barker21College of Nursing, Seattle University, Seattle WA, USA; 2Sea Mar Community Health Center, Seattle, WA, USAProblem statement: Unprecedented consumption of health care ...
Bond GE, Rechholtz L, Bosa C, Impert C, Barker S   +4 more
doaj  

Performance of a two-item screening for household food insecurity during WIC services

BMC Public Health
Background The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in California introduced household food insecurity (HFI) screening during eligibility certifications in 2019.
Christopher E. Anderson, M. Pia Chaparro, Shannon E. Whaley   +2 more
doaj   +1 more source

Polynomial manipulator AP-168 [PDF]

, 1967
Linear Systems Design Evaluation Program, AP-168 combines the many different analysis techniques used to evaluate and manipulate polynomials. The single program is a pseudo instruction abstraction.
Tutt, G. E.
core   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Evaluating Program Progress [PDF]

Public Health Reports (1896-1970), 1955
openaire   +2 more sources

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Shared decision-making and behaviour change collide: an analysis of consultations discussing clinical trial recruitment

Trials
Background Recruitment to clinical trials is often challenging, and evidence on effective recruitment strategies remains limited. Framing trial recruitment as a behaviour, amenable to change, enables the application of behavioural science frameworks to ...
Abigail Stephen, Ayodeji Matuluko, Kelly Carroll, Taylor Coffey, Louisa Lawrie, Frances Sherratt, Natasha Hudek, Fabianna Lorencatto, Justin Presseau, Susan Marlin, Dawn P. Richards, Jamie Brehaut, Katie Gillies   +12 more
doaj   +1 more source

Evaluation instrument re Boston University Program for Teachers of Legislative Drafting (1995) [PDF]

, 1995
Evaluation instrument for for the Boston University Program for Teachers of Legislative ...
Seidman, Ann, Seidman, Robert B.
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source